Skip to main content
Premium Trial:

Request an Annual Quote

ArcherDx: Jason Ryan

ArcherDx has appointed Jason Ryan to the firm's board of directors and as the chair of its audit committee. Ryan currently serves as chief operating and financial officer at Magenta Therapeutics. He previously served as CFO at Foundation Medicine before it was sold to Roche Diagnostics in 2018. 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.